Solid phase sequencing of double-stranded nucleic acids
- Waltham, MA
- Boston, MA
- Concord, MA
This invention relates to methods for detecting and sequencing of target double-stranded nucleic acid sequences, to nucleic acid probes and arrays of probes useful in these methods, and to kits and systems which contain these probes. Useful methods involve hybridizing the nucleic acids or nucleic acids which represent complementary or homologous sequences of the target to an array of nucleic acid probes. These probe comprise a single-stranded portion, an optional double-stranded portion and a variable sequence within the single-stranded portion. The molecular weights of the hybridized nucleic acids of the set can be determined by mass spectroscopy, and the sequence of the target determined from the molecular weights of the fragments. Nucleic acids whose sequences can be determined include nucleic acids in biological samples such as patient biopsies and environmental samples. Probes may be fixed to a solid support such as a hybridization chip to facilitate automated determination of molecular weights and identification of the target sequence.
- Research Organization:
- Boston University
- DOE Contract Number:
- FG02-93ER61609
- Assignee:
- Boston University (Boston, MA); Sequenom, Inc. (San Diego, CA)
- Patent Number(s):
- US 6436635
- OSTI ID:
- 874666
- Country of Publication:
- United States
- Language:
- English
Similar Records
Solid phase sequencing of biopolymers
Methods for detecting nucleic acid sequences
Related Subjects
acid
acid probe
acid sequence
acids
array
arrays
automated
biological
biopsies
chip
complementary
contain
detecting
determination
determined
double-stranded
environmental
facilitate
fixed
fragments
homologous
hybridization
hybridized
hybridizing
identification
involve
kits
mass
methods
molecular
molecular weight
nucleic
nucleic acid
optional
patient
phase
portion
probe
probes
relates
represent
samples
sequence
sequences
sequencing
set
single-stranded
solid
solid support
spectroscopy
stranded nucleic
support
systems
target
useful
variable
weights